AIM ImmunoTech (AIM) Operating Leases (2019 - 2026)
AIM ImmunoTech (AIM) reported Operating Leases of $41,000 for Q2 2026, down 85.5% from $282,000 a year earlier and down 61.0% from the prior quarter.
Powered by 
Analysis
AIM ImmunoTech (AIM) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, AIM ImmunoTech posted Operating Leases of $170,000, down 57.0% from FY2024.
- Operating Leases has declined for three consecutive years, though with a five-year compound annual growth rate of 5.2% (FY2020 to FY2025).
- By year, Operating Leases came in at $395,000 in FY2024 (-20.2%), $495,000 in FY2023 (-24.9%), $659,000 in FY2022 (+488.4%) and $112,000 in FY2021 (-15.2%).
- The Q2 2026 figure ranks as the lowest quarterly Operating Leases in data going back to Q1 2019.
- Year over year, Operating Leases has now declined in each of the last 13 quarters, with an average decline of 47.3% over the last eight quarters.
- The high point for year-over-year Operating Leases in five years was Q1 2023 (growth of 657.1%); the low point was Q2 2026 (a decline of 85.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $105,000 (Q1 2026), $170,000 (Q4 2025) and $226,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41,000.00 |
| Mar 31, 2026 | 105,000.00 |
| Dec 31, 2025 | 170,000.00 |
| Sep 30, 2025 | 226,000.00 |
| Jun 30, 2025 | 282,000.00 |
| Mar 31, 2025 | 338,000.00 |
| Dec 31, 2024 | 395,000.00 |
| Sep 30, 2024 | 437,000.00 |
| Jun 30, 2024 | 488,000.00 |
| Mar 31, 2024 | 537,000.00 |
| Dec 31, 2023 | 495,000.00 |
| Sep 30, 2023 | 543,000.00 |
| Jun 30, 2023 | 597,000.00 |
| Mar 31, 2023 | 636,000.00 |
| Dec 31, 2022 | 659,000.00 |
| Sep 30, 2022 | 695,000.00 |
| Jun 30, 2022 | 735,000.00 |
| Mar 31, 2022 | 84,000.00 |
| Dec 31, 2021 | 112,000.00 |
| Sep 30, 2021 | 108,000.00 |
API Access
AIM ImmunoTech Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();